← American Academy of Pediatrics (AAP)
FDANonrulemakingFDA-2024-D-2682

Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

RIN
—
Last modified
Sep 19, 2024
Comment window
closed 679d ago
American Academy of Pediatrics (AAP) filings
1

Activity

American Academy of Pediatrics (AAP) filed 1 comment on this docket between Sep 19, 2024 and Sep 19, 2024. 2 other organizations filed here. The comment window closed 679d ago.

What American Academy of Pediatrics (AAP) filed (1)

Sep 19, 2024· Comment from NASPGHAN, American Gastroenterological Association, American Academy of Pediatrics, Crohn's & Colitis Foundation, ICN· FDA-2024-D-2682-0026

The following organizations submit comment on the FDA's draft guidance for industry, Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; American Gastroenterological Association; American Academy of Pediatrics; Crohn's and Colitis Foundation; and Improve Care Now

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (2)

See everyone who commented →
Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability (FDA) — American Academy of Pediatrics (AAP) | OpenPolis